10 Comentários

Que artigo espetacular. Certamente um dos 3 melhores textos que li na vida - hoje, tô achando que é o número 1, por ser TÃO claro, tão necessário e tão acessível. Meus efusivos parabéns e muito obrigada.

Expand full comment
Dez 17, 2022Gostado por Filipe Rafaeli

Aproveitando a sua menção a Epidemia de 2009 - Sobre as "maravilhas" da Indústria com o Tamiflu. Parece que o modus operandi não mudou em nada:

https://youtu.be/CU3PsTd5Bg0 - "Peter Doshi -- Lessons from Tamiflu experience"

"According to a BMJ article, 'Conflict of interest forms filed by the 34 members of the external working group that wrote and reviewed the new CDC recommendation in 2012 show that nine had financial ties to the manufacturers.' The CDC Foundation also accepted conditional funding from Roche for the Take 3 flu campaign. CDC subsequently posted a recommendation on its website recommending influenza antiviral drugs (e.g. oseltamivir)" - https://www.jpands.org/vol25no3/huntoon.pdf

"Following criticism of the CDC and itsfoundation for accepting a directed donation from Roche for the agency’s Take 3 flu campaign (Step 3 tells the public to 'take antiviral medicine if your doctor prescribes it), the CDC posted an article on its website entitled, 'Why CDC Recommends Influenza Antiviral Drugs.' The agency cited multiple observational and industry funded studies, including the recent meta-analysis by Dobson and colleagues, which it described as an “independent” study. However, the study was sponsored by Roche, and all four authors had financial ties to Roche, Genentech, or Gilead (the first two sell oseltamivir and Gilead holds the patent). Despite its extensive list of studies, the CDC did not cite the systematic review and meta-analysis by the Cochrane Collaboration. The CDC told The BMJ that it didn’t include the Cochrane review because Cochrane 'did not consider any data from uncontrolled observational studies of oseltamivir treatment. While such studies have inherent design limitations, they can inform clinical practice and public health, especially when data from RCTs [randomized controlled trials] are unavailable or have not been conducted among high-risk groups or hospitalized influenza patients, or because having a placebo group would be unethical since antiviral treatment is recommended for these groups.' The US Food and Drug Administration issued a warning to Roche that it could not claim that oseltamivir reduces pneumonia or deaths since it has never provided evidence to the FDA to support that claim. Manufacturers are prohibited by law from making off-label claims about their drugs. However, doctors can legally recommend drugs for off-label uses. By funding the CDC’s Take 3 campaign, Roche and other companies are not claiming their antivirals will reduce pneumonia or death. CDC director, Frieden, however, did make the off-label claim, telling the public that it could 'save your life.'"(LENZER, 2015, p. 2) - https://www.bmj.com/content/350/bmj.h2362

Expand full comment
Abr 4Gostado por Filipe Rafaeli

Artigo muito bom. Parabéns Filipe. As estatísticas e números apresentados são soberanos. Afinal a ciência usa desse números para buscar medicamentos eficazes. Você simplesmente juntou os fatos e os números de maneira inteligente para mostrar a realidade da mesma maneira que a ciência faz. Belo trabalho!

Expand full comment
Dez 18, 2022Gostado por Filipe Rafaeli

Parabéns,Filipe! Adorei o artigo sintetizastes muito bem os crimes cometidos na pandemia de AIDS retratados no filme.Como esta figura nefasta,(Fauci) permaneceu no poder depois de tanta incompetência?(com os pacientes,já com a indústria farmacêutica...).Existe real democracia (governo do povo, maioria)em algum lugar do mundo?),somos consumidores descartáveis para meia dúzia de corporações... triste,pois estamos condenados a isto sempre se repetir.

Expand full comment
Dez 22, 2022Gostado por Filipe Rafaeli

Quem te financia?

Expand full comment

Que artigo bosta!

Expand full comment